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Abstract
Background: Knowledge about the health effects of e-cigarette use (or vaping) among past and current
combustible cigarette users is limited. Several studies have assessed vaping-related adverse events (AEs) and
beneficial health effects, however, most studies focused on AEs in general and examined only a few physiological
changes that vapers experience. This study aims to explore self-reported AEs and perceived health changes due to
e-cigarette use among Hungarian adult e-cigarette-only users (former smokers who switched completely to e-
cigarette use) and dual users (smokers who use e-cigarettes and combustible tobacco cigarettes concomitantly).
Methods: A cross-sectional, web-based survey of 1042 adult Hungarian e-cigarette users was conducted in 2015.
Participants reported AEs and changes in physiological functions since they switched from smoking to e-cigarette
use or while dually using e-cigarettes and combustible cigarettes. Confirmatory factor analysis with covariates was
applied to explain perceived health changes due to e-cigarette-only use and dual use.
Results: Dual users (17.6%) were significantly more likely to report AEs of vaping than e-cigarette-only users (26.2%
vs. 11.8%, p < 0.001). Experiencing health improvements were significantly more likely among e-cigarette-only users
than for dual users for all surveyed physiological functions. E-cigarette-only users reported larger effects of vaping
on sensory, physical functioning, and mental health factors compared to dual users. Self-reported changes in
sensory and physical functioning were significantly higher among individuals using e-cigarettes more than a year
and people who were past heavy smokers (smoked ≥20 cigarettes per day). Gender was related to sensory
improvement only; males reported greater improvement than females.
Conclusions: The majority of e-cigarette-only users reported more perceived beneficial changes in physiological
functions and fewer AEs than dual users. Perceived short-term benefits of e-cigarette use may reinforce users
despite the uncertainty of long-term health consequences. Health professionals should provide balanced
information regarding the possible short- and long-term positive and negative health effects of e-cigarette use
during consultations with patients.
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Background
Electronic cigarettes (e-cigarettes) are rapidly evolving
products with a wide range of design and engineering
variations. The basic function of all e-cigarettes is to
generate a heated aerosol typically containing nicotine,
that is inhaled through a mouthpiece [1, 2]. Some stud-
ies have shown that e-cigarettes may emit substantially
less toxic substances than combustible cigarettes [3,
4], although others have found higher metal and sili-
cate concentration in the aerosol compared to com-
bustible cigarette smoke [5], while nicotine intake
from advanced generation devices is similar to that of
tobacco cigarettes [1].
There is an ongoing debate on the potential harms or
benefits of e-cigarettes in the public health community.
Advocates of e-cigarettes emphasize the harm reduction
potential of these products as substitutes for combust-
ible tobacco among persons trying to quit or reducing
the amount of cigarette smoking (aka dual users). How-
ever, dual use will undermine the potential harm reduc-
tion due to the known short- and long-term health
effects of smoking [6]. On the other hand, opponents
argue that there are unknown long-term risks of
e-cigarette use (or vaping). These include the potential
for negative health effects, e-cigarettes serving as a gate-
way to traditional tobacco use among youth, and a de-
creased likelihood of conventional cigarette smoking
cessation [6, 7]. The overall population health effect of
e-cigarette use remains uncertain. Some data demon-
strate a favorable public health impact of switching from
cigarettes to e-cigarette use [8], while others are more
cautious, emphasizing the uncertainties of health harm,
instigating tobacco initiation among youth, and main-
taining addiction among adults [9].
Despite the debate and growing perceptions that
e-cigarettes are harmful, experimentation with
e-cigarettes is increasing in the European Union [10]. In
Hungary, there are limited data about e-cigarette use
among adults. In 2017, 27% of Hungarian persons 15
years-old and older were current smokers, and 9% had
ever tried an e-cigarette [11]. A national study con-
ducted among Hungarian young adults (mean age 21.7
years) found a 24.9% ever use rate, but low current (past
30-day) use rate of e-cigarettes (0.6%) [12].
Current knowledge about both self-reported and ob-
jectively measured health effects of e-cigarette use
among past combustible cigarette users is limited.
Among the scant literature, most health effects were
measured by self-report rather than objectively mea-
sured. In recent years, several studies have assessed
vaping-related adverse events (AEs) and beneficial health
effects. However, most studies focused on AEs in general
and consistently examined only a few physiological
changes that e-cigarette users experience. Of studies
indicating no conflicts of interest regarding support from
e-cigarette manufacturers or lobby, 84.2% of Dutch
vapers reported health improvements since e-cigarette
use initiation [13], while 84% of German ex-smoker
vapers indicated an overall feeling of living healthier
[14]. Likewise, 71% of Italian smokers who switched
from cigarettes to e-cigarettes experienced general
health improvements after three months [15]. It is un-
clear if these perceived health improvements are due to
placebo effect, reflect expectancies driven by e-cigarette
marketing, or are true physiological changes. Improve-
ments in specific physiological conditions in persons
who replace combustible cigarettes with e-cigarettes are
less well-documented. Besides respiratory, cardiovascular
and sensory changes associated with vaping, other
physiological changes have been observed, for instance,
in periodontal health, appetite, quality of sleep, mood,
and sexual performance [2, 13–18]. Although hundreds
of vaping-related AEs have been registered [16],
e-cigarette users report mostly mild AEs, including
mouth/throat irritation, dry cough, dry mouth, dizziness
and headache [17, 19, 20].
This study aims to explore self-reported health effects
of vaping among Hungarian adult e-cigarette-only users
(former smokers who switched completely to
e-cigarettes) and dual users (smokers who use
e-cigarettes and combustible tobacco cigarettes con-
comitantly). Our objectives were (1) to describe charac-
teristics of Hungarian adult e-cigarette-only and dual
users, (2) to assess self-reported AEs and changes in
physiological functions after e-cigarette use initiation
among e-cigarette-only and dual users, and (3) to ex-
plain perceived health changes due to e-cigarette use.
Methods
Participants and procedure
A cross-sectional online survey was conducted among
adult (age 18+) Hungarian e-cigarette users in Septem-
ber–December, 2015. The convenience sample was ob-
tained by posting the survey on Hungarian e-cigarette
forum websites (www.ecigiforum.com, www.ecigiblog.
blog.hu, www.ecigaretta.eu) and an e-cigarette webshop
(www.sbcig.com) inviting website visitors to participate.
After reading the description of the study, participants
consented to participate by voluntarily answering the
survey questions. A lottery-based incentive was offered
after two months to increase participation. 800 partici-
pants completed the survey anonymously without the
incentive, and 784 completed the survey after the incen-
tive was introduced, indicating their e-mail address to
participate in the lottery. The study was approved by the
Institutional Review Board of Semmelweis University,
Budapest, Hungary.
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Of the 1584 initial respondents, we excluded the fol-
lowings: those who were < 18-year-old (n = 4); had never
smoked (n = 22); did not respond whether they used
e-cigarette and/or combustible cigarette (n = 63); and
responded inconsistently to questions assessing
e-cigarette-only and dual use (n = 40). Since we did not
have access to respondents’ internet protocol (IP) ad-
dress to exclude multiple responses from the same par-
ticipants, we searched for duplicate cases (n = 413) using
all socio-demographic variables (gender, age, education
level, type of settlement, income level). We applied an a
priori decision rule that only the first case of potential
duplicate respondents was included in the final analyt-
ical sample. As a result, 1042 unique respondents who
ever smoked and were current e-cigarette users (only or
dual users) were included in the study.
Measures
The questionnaire consisted of seven parts: (1)
socio-demographic characteristics of respondents, (2)
e-cigarette use, (3) perceived harm of e-cigarette use, (4)
combustible cigarette use, (5) oral hygiene, (6)
vaping-related adverse events, and (7) changes in physio-
logical functions (see Additional file 1 for full question-
naire). The following variables were included in the
current study:
Socio-demographic data were collected on gender, age
(range 18–75, mean age 38.9 [SD = 11.8]), and education
(technical school or less – without graduation certificate,
high school or vocational school – with graduation cer-
tificate, and college or university).
E-cigarette-only versus dual use was assessed by a ques-
tion “Do you use e-cigarette or combustible cigarette?”
(combustible cigarettes only, e-cigarettes only, both of
them). Only persons who were e-cigarette-only users
and dual users were included in the study.
Past combustible cigarette use was measured by the
number of tobacco cigarettes smoked per day before ini-
tiating e-cigarette use. Response options were catego-
rized into: ≤10 CPD – light smoker, 11–19 CPD –
moderate smoker, ≥20 CPD – heavy smoker.
Current e-cigarette use characteristics variables included
in this study were (1) time since respondent started
using e-cigarettes (< 6 month ago, 6–12months ago, 1–
2 years ago, > 2 years ago), (2) frequency of e-cigarette
use per day (non-daily, 1–10 times a day, 11–19 times a
day, ≥20 times a day), and (3) nicotine concentration of
the e-liquid (0 mg/ml – 18mg/ml or more) (Table 1).
Vaping-related adverse events were assessed in a ques-
tion where participants could indicate (yes/no) if they
had experienced any of 14 AEs (Table 2) [17]. Any AEs
variable was computed based on responses for the 14
listed conditions (no AEs/any AEs).
Changes in physiological functions were measured by a
question listing 10 physiological functions (Table 2) and
respondents were asked if they experienced worsening,
no change or improvement of each listed health condi-
tions since they initiated e-cigarette use [17]. Response
options were collapsed into a binary variable (worsened/
no change vs. improved categories) due to low frequen-
cies (0.0–0.6%) of worsened categories of physiological
functions variables in the sample.
Statistical analysis
Descriptive characteristics of the sample, self-reported
AEs and changes in physiological functions by current
e-cigarette use status were assessed in Pearson’s
chi-square test using SPSS version 24.0. Odds of physio-
logical function improvement were tested among
e-cigarette-only users compared to dual users with bin-
ary logistic regression analyses. The covariances among
physiological functions made it necessary to identify the
latent factors of health improvement with confirmatory
factor analysis (see Brown [21]). Exploratory factor ana-
lysis (EFA) and confirmatory factor analysis (CFA) iden-
tify the latent variables behind the different groups of
physiological functions, therefore confirmatory factor ana-
lysis with covariates (CFA with covariates) was applied to
explain perceived improvements in health due to
e-cigarette use using Mplus 8.0 [22]. CFA includes first
testing the measurement model of improvements. Theor-
etically, we propose three different aspects of improve-
ments including sensory improvement, physical
functioning, and mental health improvement. After sup-
porting this measurement model of health improvements,
we introduced the structural components of the model,
therefore CFA with covariates model can estimate the ef-
fect of indicators on latent variables at the same time
when direct effects of grouping variables or other continu-
ous variables on the latent variables are also included.
Results
Compared to dual users (17.6%), e-cigarette-only users
(82.4%) were more likely to be male and started using
e-cigarettes more than two years prior to the survey
(Table 1). The majority of e-cigarette-only users reported
vaping more than 20 times a day while only half of dual
users responded similarly. Using low nicotine concentra-
tion e-liquid (1–6 mg) was reported by 52.1% of
e-cigarette-only users, while similar proportion of dual
users used medium (7–12 mg) or high (≥13 mg) nicotine
concentration e-liquid. There were no significant dif-
ferences by mean age, educational level, or combust-
ible cigarettes smoked per day before initiating
e-cigarette use between the two groups, however,
60.1% of the whole sample was heavy smoker while
9.7% was light smoker.
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Any AEs were reported by 14.3% of the sample and
significantly more likely among dual versus
e-cigarette-only users (26.2% vs. 11.8%, p < 0.001). The
majority of respondents reported ≤2 AEs (94.0%). The
most common AE was cough among dual users and
sore/dry mouth and throat among e-cigarette-only users
(Table 2). Mouth and throat-related AEs were commonly
reported by e-cigarette-only users while dual users indi-
cated mostly cough and oral cavity AEs. Significantly
more dual users experienced cough, mouth or tongue
sores/inflammation, dizziness, and heart palpitation than
e-cigarette-only users.
The majority of the sample reported better breathing,
olfactory and gustatory senses since initiating e-cigarette
use (Table 2), while improvement in sexual performance
and memory were reported less frequently. About
90%-of e-cigarette-only users experienced better breath-
ing, sense of smell and taste while a bit more than
two-thirds of dual users did so. Improved mood, sleep
quality and appetite were reported by about half of
e-cigarette-only users compared to one-third of dual
users. About one-third of e-cigarette-only users and 20–
25% of dual users indicated improvements in sexual
performance and memory. Experiencing health improve-
ments were significantly more likely among
e-cigarette-only users than for dual users for all surveyed
physiological functions.
Predictors of health improvements due to e-cigarette use
We performed a series of binary logistic regression ana-
lyses to compare the odds of health improvements in
both types of users. The unadjusted and adjusted odds
Table 1 Descriptive characteristics of the sample by vaping status
Variable Total, n (%)
1042 (100)
E-cigarette-only user,
n (%)
859 (82.4)
Dual user,
n (%)
183 (17.6)
p-value
Gender
Male 859 (82.9) 726 (85.0) 133 (73.1) < 0.001
Female 177 (17.1) 128 (15.0) 49 (26.9)
Age (years)
Mean (SD) 38.9 (11.8) 38.8 (11.7) 39.0 (12.6) 0.843
Education
Technical school or less (without graduation certificate) 235 (24.6) 200 (25.4) 35 (21.0) 0.120
High school or vocational school (with graduation certificate) 416 (43.6) 348 (44.2) 68 (40.7)
College or university 303 (31.8) 239 (30.4) 64 (38.3)
Time since started using e-cigarette
Less than 6 months ago 195 (19.0) 147 (17.3) 48 (26.7) 0.007
6–12 months 192 (18.7) 155 (18.3) 37 (20.6)
1–2 years 219 (21.3) 181 (21.3) 38 (21.1)
More than 2 years ago 423 (41.1) 366 (43.1) 57 (31.7)
Frequency of e-cigarette use
Non-daily 21 (2.0) 8 (0.9) 13 (7.2) < 0.001
1–10 times a day 103 (10.0) 76 (9.0) 27 (15.0)
11–19 times a day 234 (22.8) 184 (21.7) 50 (27.8)
≥ 20 times a day 668 (65.1) 578 (68.3) 90 (50.0)
Combustible cigarettes smoked per day (before started using e-cigarette)
≤ 10 cigarettes per day 101 (9.7) 82 (9.5) 19 (10.7) 0.468
11–19 cigarettes per day 307 (29.6) 249 (29.0) 58 (32.8)
≥ 20 cigarettes per day 628 (60.6) 528 (61.5) 100 (56.5)
Nicotine concentration of e-liquid
0 mg 77 (7.5) 60 (7.0) 17 (9.4) 0.009
1–6 mg 514 (49.8) 444 (52.1) 70 (38.7)
7–12 mg 349 (33.8) 272 (31.9) 77 (42.5)
≥ 13mg 93 (9.0) 76 (8.9) 17 (9.4)
Note: Some categories do not add to the total due to missing responses
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ratios are presented in Table 3. Compared to dual users,
e-cigarette-only users had more than three times higher
odds perceiving improvement in smelling, breathing,
tasting and stamina; and reported about two times
higher odds improvement in physical status, mood and
sleep quality. There were no significant differences in
the odds of improvement in appetite, sexual perform-
ance and memory between e-cigarette-only users and
dual users.
We also performed an exploratory factor analysis
(EFA) followed by a confirmatory factor analysis (CFA)
to estimate the measurement model of improvement in
health. We supported three main factors of physiological
functions (Fig. 1). The details of this psychometric ana-
lysis are available in Additional file 2. The standardized
regression coefficients of CFA with covariates are pre-
sented in Table 4. Compared to dual users,
e-cigarette-only users reported greater improvement in
Table 2 Prevalence of vaping-related adverse events and perceived improvement in physiological functions
Variable Total, n (%)
1042 (100)
E-cigarette-only user, n (%)
859 (82.4)
Dual user,
n (%) 183 (17.6)
p-value
Adverse events
Sore/dry mouth and throat 39 (3.7) 30 (3.5) 9 (4.9) 0.356
Cough 42 (4.0) 18 (2.1) 24 (13.1) < 0.001
Mouth or tongue sores/inflammation 30 (2.9) 19 (2.2) 11 (6.0) 0.005
Gingivitis, gum bleeding 34 (3.3) 27 (3.1) 7 (3.8) 0.637
Headache 18 (1.7) 13 (1.5) 5 (2.7) 0.251
Dizziness 10 (1.0) 5 (0.6) 5 (2.7) 0.007
Heart palpitation 14 (1.3) 8 (0.9) 6 (3.3) 0.012
Breathing difficulties 10 (1.0) 6 (0.7) 4 (2.2) 0.061
Chest pain 7 (0.7) 4 (0.5) 3 (1.6) 0.078
Sleepiness 3 (0.3) 2 (0.2) 1 (0.5) 0.472
Sleeplessness 3 (0.3) 2 (0.2) 1 (0.5) 0.472
Allergy 2 (0.2) 2 (0.2) 0 (0.0) 0.514
Black tongue 1 (0.1) 1 (0.1) 0 (0.0) 0.644
Nose bleeding 1 (0.1) 1 (0.1) 0 (0.0) 0.644
Any adverse event 149 (14.3) 101 (11.8) 48 (26.2) < 0.001
Physiological function
Breathing 930 (90.1) 790 (92.7) 140 (77.8) < 0.001
Smell 890 (86.1) 767 (90.0) 123 (67.6) < 0.001
Taste 864 (83.6) 744 (87.2) 120 (66.7) < 0.001
Physical status in general 833 (80.9) 715 (84.1) 118 (65.6) < 0.001
Stamina 800 (77.7) 697 (82.0) 103 (57.5) < 0.001
Mood 524 (51.1) 461 (54.5) 63 (35.2) < 0.001
Quality of sleep 469 (45.8) 406 (48.1) 63 (34.8) 0.001
Appetite 412 (40.4) 355 (42.2) 57 (31.7) 0.009
Sexual performance 351 (34.4) 306 (36.3) 45 (25.3) 0.005
Memory 282 (27.7) 246 (29.2) 36 (20.3) 0.016
Table 3 Perceived improvement in physiological functions in
e-cigarette-only users and dual users: binary logistic regression
analyses
Variable OR [95%CI] ORadjusted
a [95%CI]
Breathing 3.64 [2.35–5.63] 3.39 [2.15–5.33]
Smell 4.33 [2.95–6.35] 4.12 [2.77–6.12]
Taste 3.41 [2.36–4.94] 3.21 [2.18–4.72]
Physical status in general 3.36 [2.38–4.74] 2.28 [1.56–3.32]
Stamina 3.36 [2.38–4.74] 3.11 [2.17–4.45]
Mood 2.21 [1.58–3.08] 2.09 [1.48–2.96]
Quality of sleep 1.74 [1.24–2.43] 1.70 [1.21–2.41]
Appetite 1.58 [1.12–2.20] 1.57 [1.09–2.25]
Sexual performance 1.68 [1.17–2.43] 1.68 [1.14–2.48]
Memory 1.62 [1.09–2.40] 1.59 [1.06–2.40]
Note: Reference group is dual users. a: adjusted for age, gender, and duration
of e-cigarette use. All ORs are significant at least at p < 0.050. Bolded ORs
remained significant after Bonferroni correction for multiple testing. The
adjusted level of significance after Bonferroni correction is p < 0.005
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all three dimensions. Improvements in sensory and
physical functioning were significantly higher among in-
dividuals using e-cigarettes more than a year and people
who used to smoke ≥20 CPD, however the size of the
difference was highest in sensory improvement factors
for the latter variable. Gender was related to sensory im-
provement only; males reported greater improvements
than females.
Discussion
Our study found that e-cigarette-only users report more
perceived improvement in health and less adverse health
effects of vaping than dual users. The majority of
e-cigarette-only users reported better respiratory and
sensory functions and indicated only minor AEs since they
started using e-cigarettes. However, dual users were prob-
ably under-represented while satisfied e-cigarette-only
users were over-represented, therefore, our results may
overestimate perceived benefits of vaping [14, 23]. Fur-
thermore, the majority of respondents were heavy smoker
before e-cigarette use initiation, and only about 10% were
light smoker. To our knowledge, this is the first study to
explore different dimensions of perceived health changes
due to e-cigarette use in a mostly past heavy smoker
sample.
Improved olfactory and gustatory functions, both sen-
sory improvements, were frequently reported benefits of
vaping in both independent and sponsored studies [13,
Fig. 1 Measurement model of health changes due to e-cigarette use. Standardized factor loadings are presented
Table 4 Predictors of perceived health improvements since initiating e-cigarette use: confirmatory factor analysis with covariates
model
Variable Sensory improvement Physical functioning Mental health improvement
Gender −0.32 −0.12 −0.06
Dual users −0.56 −0.50 −0.29
Age −0.01 −0.01 −0.01
Any adverse event due to e-cigarette use −0.58 −0.55 −0.25
Educational level 0.07 − 0.08 − 0.09
Duration of e-cigarette use 0.23 0.24 0.12
Intensity of smoking before e-cigarette use 0.33 0.26 0.16
High nicotine content of e-liquid 0.14 −0.08 0.06
R2 16.7% 13.6% 4.2%
Note: Partial regression coefficients. Bolded coefficients are significant at p < 0.05. Gender (0: Males, 1: Females). Dual users (0: e-cigarette-only users, 1: Dual users).
Age is continuous variable. Any adverse event due to e-cigarette use (0: No adverse event, 1: Report of any adverse event). Educational level (0: Lower than
college level education, 1: College or higher level of education). Duration of e-cigarette use (0: A year or less, 1: Longer than a year). Intensity of smoking before
e-cigarette use (0: ≤19 cigarettes per day, 1: ≥20 cigarettes per day). High nicotine content of e-liquid (0: ≤6 mg or nicotine-free, 1: ≥7mg nicotine)
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15, 17, 23]. High intensity past tobacco smoking and
longer e-cigarette use history predicted greater sensory
improvements, but only among males. Olfactory dys-
function is more likely among current smokers com-
pared to never smokers, and reduced olfactory ability
depends on tobacco smoke dose-duration [24]. Further-
more, smoking-related olfactory dysfunction is reversible
due to reversible squamous metaplasia of the olfactory
mucosa [24]. Gustatory dysfunction may rather reflect
olfactory dysfunction [25], which can explain com-
bined improvement of taste and smell sensation after
smoking cessation. Lower exposure to potentially
toxic substances from e-cigarettes compared to com-
bustible cigarettes [3] might have a similar but likely
weaker effect on the olfactory mucosa similar to ces-
sation, which leads to the regeneration of squamous
metaplasia within six months [24].
Improved breathing, general physical status and stam-
ina were correlated with past combustible cigarette
smoking habits and e-cigarette use duration. The most
commonly reported improvement among these physio-
logical functions was breathing in our whole sample,
consistent with studies of Dutch vapers, and a large
international sample of a sponsored study involving
more than 19,000 e-cigarette users where almost 90% of
respondents reported better breathing due to vaping [13,
17, 23]. However, studies investigating respiratory out-
comes of e-cigarette use are contradictory. Some studies
have demonstrated that short-term e-cigarette use has
an acute negative effect on the respiratory system, like
impaired lung function and increased airway resistance
both among healthy smokers and nonsmokers, and
smokers with asthma or COPD [20, 26]. In contrast,
others reported no significant short-term changes in
lung function parameters among healthy smokers
switching to e-cigarettes [18, 27], although studies
sponsored by e-cigarette manufacturers and mer-
chants found improvements in spirometric indices
and respiratory symptoms on long-term [28, 29]. A
large proportion of Hungarian e-cigarette-only users
indicated improvement in physical status and endur-
ance similarly to other studies [13–15, 17, 23]. These
positive changes may be associated with perceived im-
provements in respiratory health.
E-cigarette-only users experienced significantly greater
improvements in mental health. They reported greater
improvements in their mood and quality of sleep com-
pared to a large international study [17] and a smaller
one from the Netherlands [13]. However, a study by
Adriaens et al. (2017) did not detect significant differ-
ences between dual users and switchers (smokers who
completely switched to e-cigarette use) in moderate im-
provement of mood and sleep quality [23]. Possible ex-
planations for mood improvement could be positive
expectancies towards e-cigarette use [30], satisfying con-
trol on nicotine delivery by advanced generation
e-cigarettes [1], perceived supervision of withdrawal
symptoms [31], and self-efficacy to change tobacco
smoker identity toward a perceived healthier e-cigarette
user identity. Adult smokers and former smokers with
mental health conditions seem to be more susceptible to
trying e-cigarettes and to be current vapers as they per-
ceive them an appealing and less harmful substitutes for
conventional cigarettes [32]. Improvements in mood and
psychological quality of life as well as perceived better
respiratory function might explain positive changes in
sleep quality. Nevertheless, a study examining online
e-cigarette forum posts related to positive and negative
health effects of e-cigarette use explored more negative
complaints than positive changes of sleep disorders [16].
Positive changes in memory were reported by a minor-
ity of our sample similarly to another study [17]. A pre-
vious research explored that memory improved only
among individuals using nicotinic e-cigarettes presum-
ably because of impaired memory during smoking ab-
stinence that was reversed by nicotinic e-cigarettes [31].
Sexual performance has rarely been investigated as it
pertains to e-cigarette use. Approximately one third of
e-cigarette-only users in our sample agreed that their
sexual performance improved since they initiated vaping,
similarly to an international study which found 28.9%
improvement rate [17]. This association is suspected to
be complex. On the one hand, nicotine may cause acute
vasospasm while other components of tobacco smoke
are atherogenic on a dose-response manner both in the
male and female genital tract [33, 34]. If e-cigarettes de-
liver much less toxicants than conventional cigarettes
[3], but nicotine delivery by advanced generation devices
are as effective as by conventional cigarettes [1], im-
provement in sexual performance might be expected in
individuals with shorter duration and less intense life-
time smoking. On the other hand, better-functioning re-
spiratory and sensory systems may positively influence
sexual performance of former smokers switching to
e-cigarettes.
Almost two-thirds of dual users and more than half of
e-cigarette-only users did not report improved appetite
consistent with a few other studies detecting greater im-
provement in appetite among switchers compared to
dual users [17, 23]. It is suspected that both nicotinic
and nicotine-free e-cigarettes may prevent weight gain
through influencing body metabolism by nicotine and
other e-liquid constituents, and providing an alternative
activity to eating by replacing high calorie foods with
sensory experiences like desirable taste and smell of the
vapor [35, 36]. A recent study explored that the popular
vanilla-flavored e-liquid was associated with vaping to
lose/control weight as it may serve as a distractor from
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or substitute for high calorie foods [35]. Carbohydrate
intake increases after cessation because former smokers
perceive the sweet taste more pleasant than smokers
possibly due to the activation of central reward centers
during nicotine withdrawal [37]. E-cigarettes may have
the potential to support and sustain quitting by reducing
appetite and weight gain, but in contrast they may also
promote the initiation of e-cigarette use for appetite/
weight control purposes among non-tobacco users [36].
In our analysis, we also identified three main dimen-
sions of perceived health improvements attributed to
e-cigarette use. Sensory improvement included improved
smell and taste. The improvement in physical function-
ing encompassed improved breathing, physical
well-being and improved stamina. Finally, the mental
health improvement factor incorporated the improved
appetite, sexual life, mood, memory and sleeping. We
also noted that dual users reported much lower degree
of improvement in all three dimensions than
e-cigarette-only users. This result highlights that greater
perceived health improvements are related with the
complete cessation of regular cigarette use. Longer dur-
ation of e-cigarette use was associated with higher score
on sensory improvement and physical functioning. Inter-
estingly, intensity of smoking before e-cigarette use was
also associated with greater improvement in sensory and
physical functioning dimensions suggesting that heavy
smokers compared to light smokers may gain much
more from switching to e-cigarette from combustible
cigarette. Furthermore, our study provides a useful
self-report tool to measure perceived health effects due
to vaping for future studies.
Regarding AEs, mouth and throat, respiratory and
neurological symptoms were the most frequently re-
ported by a minority of Hungarian vapers parallel with
other studies indicating similar side-effect patterns [16,
17, 19, 20, 23, 27]. Possible explanations of mouth and
throat symptoms are multiple. Longer and harder puff-
ing with stronger vacuum is necessary for vaping than
for conventional cigarette smoking to produce aerosol
[38]. Vacuum generation might involve the tongue, the
palate and also the bucca, therefore, these oral regions
may be exposed more directly to the vapor [39]. More-
over, glycerin, propylene-glycol, and e-liquid flavorings
might form thermal degradation byproducts during
vapor generation which may be also a cause of tongue
and/or buccal pain as well as mouth and throat irritation
[19, 39]. Finally, inhalation of e-cigarette aerosol ele-
ments like silicon, sulfur, calcium, titanium, and lithium
are associated with throat irritation [5]. Gingivitis and
gum bleeding were experienced by our respondents like
in previous studies [17, 40]. It is suspected that tobacco
smoke-generated vascular changes in the gingiva re-
solves similarly during vaping and smoking cessation,
that is, inflammatory response increases and vasocon-
striction decreases in the gingiva [40].
Among AEs, cough was more frequently reported es-
pecially by dual users than breathing difficulties. How-
ever, cough was less commonly mentioned in our
sample compared to previous studies reporting frequen-
cies between 12.8–69.0% [17, 18, 20, 28]. Possible mech-
anism of cough is a vagal mediated protective reflex
generated by inhaled irritants from the vapor like
propylene-glycol and/or flavorings [20]. Experiencing
neurological AEs (e.g., headache and dizziness) were rare
among Hungarian vapers, although some previous stud-
ies indicated more common occurrence [16–18, 27].
Cardiovascular AEs such as heart palpitation and chest
pain were also infrequent especially among
e-cigarette-only users compared to other studies [16, 17,
20]. A possible mechanism of neurological and cardio-
vascular symptoms is short-term increase of heart rate
and blood pressure following e-cigarette use, however
findings on blood pressure changes after vaping were in-
consistent in previous studies [2]. Additionally, learning
period of puffing behavior with a newer generation
e-cigarette could result in a nicotine boost and possibly
excessive nicotine delivery may leads to increased heart
rate and chest pain due to myocardial hypoxia [2, 41].
Other AEs were sporadic and even less frequent than re-
ported in previous studies [16, 17].
This study provides more insights to patterns of per-
ceived beneficial and adverse health effects of vaping,
however, limitations exist. First, self-reported data are
prone to recall and social desirability bias, particularly
past tobacco smoking habits and experiencing AEs and
physiological changes. Second, individuals with more
positive perceptions and experiences of vaping may have
been more motivated to participate in the survey leading
to respondent bias. Third, the cross-sectional design and
convenience sample limit causal inference. Fourth, we
cannot separate the impact of positive expectancies for
vaping or a placebo effect from improvements due to re-
ducing combustible cigarette use or quitting smoking.
Furthermore, we cannot exclude also the possibilities of
a general response tendency toward the improvement in
functions in self-report due to cognitive dissonance or
other self-servicing biases. The possibility of these effects
is reflected in relatively high correlations between factors
of perceived health improvement. Sixth, like prior re-
search, we did not compare perceived health impacts of
switching to e-cigarettes to complete tobacco use abstin-
ence which would be the optimal strategy to reduce
tobacco-induced harm. We also do not have data on the
long-term stability of the perceived benefits. Seventh,
perceived improvement in health is influenced by several
factors that we may did not measure which can explain
the relatively low explained variance of health
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improvement factors. Further research should investigate
those factors that can influence how e-cigarette users
perceive and report health benefits from their product
use. Finally, this study similar to others, is based on a
convenience sample of users, therefore the
generalization of results is limited, however having a
representative sample of e-cigarette users is difficult to
define, and rarely applied in e-cigarette research. Fur-
thermore, the pattern of e-cigarette use is continuously
changing which may also limit the generalizability of our
results.
Conclusions
In conclusion, our study supports that the majority of
e-cigarette-only users report more perceived beneficial
changes in physiological functions while less AEs than
dual users. However, perceived short-term benefits of
e-cigarette use may reinforce users despite the uncer-
tainty of long-term health consequences. Further re-
search needs to determine the role of placebo effects
and expectancies on objectively measured health im-
provements associated with switching from combustible
cigarettes to e-cigarettes. Health professionals should
provide balanced information regarding the possible
short- and long-term health effects of e-cigarettes during
consultations with patients. E-cigarettes are not without
negative health consequences as numerous minor and
some major adverse events have been reported previ-
ously and in our study [6]. Furthermore, it remains un-
certain whether e-cigarettes can serve as an effective
cessation aid, while other approved cessation supports
already exists, including over-the-counter nicotine re-
placement and pharmacotherapy options. However,
long-term success rates of first-line, evidence-based
smoking cessation support remains underutilized and
their long-term efficacy is limited [19, 42]. Future studies
should measure e-cigarette use patterns and product
characteristics that influence perceived and objective
health impacts.
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